GL1X · GenesisL1 explorer

Research workbench

Novel, potent small molecule inhibitors of the molecular chaperone HSP90 discovered through structure-based design

Analyse Novel, potent small molecule inhibitors of the molecular chaperone HSP90… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2BSM
Type
protein
Length
208 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Heat shock protein HSP90-alpha
UniProt
P07900
Ligands
BSM
Pockets
1 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHeat shock protein HSP90-alphaprotein20843% helix, 23% strandP07900

Ligands and binding sites

  • BSM · 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-(4-methoxyphenyl)-1H-pyrazole-3-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11660.600.8326BSM

Compared structures

  • 2BSM · Novel, potent small molecule inhibitors of the molecular chaperone Hsp90 discovered… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.